Fu, K.; Wang, Y.; Duan, L.; Zhang, Z.; Qian, J.; Chen, X.; Liang, Y.; Lu, C.; Zhao, D.
Influence of CYP2D6, CYP3A, and ABCG2 Genetic Polymorphisms on Ibrutinib Disposition in Chinese Healthy Subjects. Pharmaceuticals 2025, 18, 1615.
https://doi.org/10.3390/ph18111615
AMA Style
Fu K, Wang Y, Duan L, Zhang Z, Qian J, Chen X, Liang Y, Lu C, Zhao D.
Influence of CYP2D6, CYP3A, and ABCG2 Genetic Polymorphisms on Ibrutinib Disposition in Chinese Healthy Subjects. Pharmaceuticals. 2025; 18(11):1615.
https://doi.org/10.3390/ph18111615
Chicago/Turabian Style
Fu, Kejia, Yao Wang, Lingyan Duan, Zhenyuan Zhang, Jialing Qian, Xijing Chen, Yi Liang, Chengcan Lu, and Di Zhao.
2025. "Influence of CYP2D6, CYP3A, and ABCG2 Genetic Polymorphisms on Ibrutinib Disposition in Chinese Healthy Subjects" Pharmaceuticals 18, no. 11: 1615.
https://doi.org/10.3390/ph18111615
APA Style
Fu, K., Wang, Y., Duan, L., Zhang, Z., Qian, J., Chen, X., Liang, Y., Lu, C., & Zhao, D.
(2025). Influence of CYP2D6, CYP3A, and ABCG2 Genetic Polymorphisms on Ibrutinib Disposition in Chinese Healthy Subjects. Pharmaceuticals, 18(11), 1615.
https://doi.org/10.3390/ph18111615
